-
公开(公告)号:US20230066280A1
公开(公告)日:2023-03-02
申请号:US17793221
申请日:2021-01-18
Applicant: UCL BUSINESS LTD
Inventor: Melissa RAYNER , James PHILLIPS , Jess HEALY , Duncan CRAIG , Gareth WILLIAMS , Ana Rita Marques Pereira TRINDADE , Karolina DZIEMIDOWICZ , Victoria ROBERTON , Holly GREGORY , Desponia ELEFTHERIADOU
IPC: A61L27/36 , A61L27/18 , A61L27/54 , A61L27/58 , A61K31/192
Abstract: The invention relates to a nanofibrous material comprising a drug for treating a peripheral nerve injury by delivering the drug locally to a damaged or injured nerve. The drug may be such a Non Steroidal Anti Inflammatory Drug or a PPAR agonist. In particular, the invention relates to a drug eluting nerve wrap or bandage that can be wrapped around an injured peripheral nerve. The invention also relates to a nanofibrous drug delivery system or device for delivering a drug locally to a peripheral nerve, a treatment for a peripheral nerve injury comprising contacting a damaged nerve with the drug eluting nanofibrous material or drug delivery system, kits and methods for making the nanofibrous materials, and uses of the nanofibrous materials.
-
公开(公告)号:US20230044220A1
公开(公告)日:2023-02-09
申请号:US17786643
申请日:2020-12-18
Applicant: UCL BUSINESS LTD
Abstract: The present invention relates to expression constructs and viral and other vectors for the treatment and/or prevention of chronic pain.
-
公开(公告)号:US20230032817A1
公开(公告)日:2023-02-02
申请号:US17641798
申请日:2019-09-10
Applicant: UCL BUSINESS LTD
Inventor: Mustafa Emre Sener , Daren Joseph Caruana
IPC: C23C16/513 , C23C16/448 , C23C16/06 , C23C28/02
Abstract: Processes and apparatus are described for atmospheric pressure plasma jet deposition onto a substrate. The process comprises feeding a solution comprising a dissolved metal precursor into a plasma jet. The dissolved metal precursor comprises a precursor metal selected from Groups 2 to 16, with the proviso that the precursor metal does not comprise Mn. The plasma jet is directed towards a surface of the substrate such that material from the plasma jet becomes deposited onto the surface of the substrate. The process provides a means to manufacture conductive, semiconducting or insulating deposits on a substrate in a material-efficient manner without the need for high-temperature post-treatment steps.
-
公开(公告)号:US11560380B2
公开(公告)日:2023-01-24
申请号:US17611890
申请日:2020-05-15
Applicant: UCL Business Ltd
Inventor: Stephen Neidle , Richard Angell , Sally Oxenford
IPC: C07D471/04 , A61P35/00
Abstract: The present invention relates to naphthalene diimides, NDIs, and methods of synthesising them. The NDIs have DNA-quadruplex binding and stabilising activity, and potential in treatment of pancreatic, prostate, and other human cancers. The NDIs are a compound of Formula I.
-
公开(公告)号:US20230003646A1
公开(公告)日:2023-01-05
申请号:US17784836
申请日:2020-12-14
Applicant: UCL BUSINESS LTD.
Inventor: John HALES , Paul DALBY
IPC: G01N21/64
Abstract: A method of quantifying the concentration of a protein of interest, or the concentration of a conformational state of the protein of interest, in a mixture, wherein the protein of interest or conformational state has an intrinsic fluorescence decay signature. The method comprises: addressing the mixture with one or more pulses of light, wherein the light has a wavelength in the 240-295 nm range, preferably in the 250-280 nm range, further preferably wherein the laser light has a wavelength of 266 nm. The method further comprises: taking a series of measurements of the fluorescence intensity of the mixture at a series of time points where the time interval between a fluorescence measurement and a preceding light pulse is recorded. The series of measurements comprises measurements for which the time intervals differ from each other by less than a nanosecond, and where the difference between largest and smallest time intervals is at least 10 nanoseconds (ns) and/or a sufficient time to detect a decay of the fluorescence intensity towards a baseline level, such that the series of measurements defines a fluorescence decay curve. The method further comprises quantifying the concentration of a protein of interest or conformational state of the protein of interest in the sample by reference to the fluorescence decay curve.
-
公开(公告)号:US20220364175A1
公开(公告)日:2022-11-17
申请号:US17846157
申请日:2022-06-22
Applicant: Yeda Research and Development Co. Ltd. , UCL Business Ltd
Inventor: Eran HORNSTEIN , Iddo MAGEN , Nancy-Sarah YACOVZADA , Jonathan ROHRER , Pietro FRATTA
IPC: C12Q1/6883 , G01N33/68
Abstract: A method of diagnosing Frontotemporal dementia (FTD) in a subject in need thereof is provided. The method comprising detecting a level of at least one micro RNA (miR) selected from the group consisting of hsa-miR-361-5p, hsa-miR-629-5p, hsa-miR-628-3p, hsa-miR-379-5p, hsa-miR-1-3p, hsa-miR-26a-5p, hsa-miR-125a-5p, hsa-miR-125b-5p, hsa-miR-142-5p and hsa-miR-340-5p in a biological sample of the subject, wherein when said level of said at least one micro RNA (miR) is higher than that in a control sample, it is indicative of FTD.
-
公开(公告)号:US11492408B2
公开(公告)日:2022-11-08
申请号:US15028113
申请日:2014-10-10
Applicant: UCL BUSINESS LTD
Inventor: Martin Pulé , Kwee Yong , Lydia Lee , Neil Chaplin
IPC: C07K16/28
Abstract: The present invention provides a bi-specific molecule which comprises: (i) a first domain which binds B cell maturation antigen (BCMA) and comprises at least part of a proliferation-inducing ligand (APRIL); and (ii) a second domain capable of activating a T cell. The invention also provides the use of such a molecule in the treatment of plasma-cell mediated diseases, such as multiple myeloma.
-
公开(公告)号:US11419920B2
公开(公告)日:2022-08-23
申请号:US17010595
申请日:2020-09-02
Applicant: UCL BUSINESS LTD , ST. JUDE CHILDREN'S RESEARCH HOSPITAL
Inventor: Amit Nathwani , Jenny McIntosh , Edward Tuddenham , Andrew Davidoff
IPC: C12N15/09 , A61K38/37 , C07K14/755 , A01K67/027 , A61K48/00
Abstract: There is provided a nucleic acid molecule comprising a nucleotide sequence encoding a Factor VIII protein, wherein a B domain portion of the Factor VIII protein is encoded by a nucleotide sequence between 90 and 111 nucleotides in length and has an amino acid sequence that is at least 85% identical to SEQ ID NO: 4 which comprises six asparagine residues. Also provided is a Factor VIII protein, a vector comprising the above nucleic acid molecule, a host cell, a transgenic animal, a method of treating Haemophilia for example, Haemophilia A, and a method for the preparation of a parvoviral gene delivery vector.
-
公开(公告)号:US11419839B2
公开(公告)日:2022-08-23
申请号:US16723241
申请日:2019-12-20
Applicant: UCL BUSINESS LTD
Inventor: Robin Simon Brooke Williams , Matthew Walker
IPC: A61K31/20
Abstract: A compound having the formula (I) R1-COOH. R1 is an alkyl or alkenyl group having a C7-11 backbone, optionally branched with a C1-6 alkyl group at any C position in the backbone, or a pharmaceutically acceptable salt, amide or ester thereof. The backbone of the alkyl or alkenyl group, and/or the branched alkyl groups, are optionally interrupted by one or more heteroatoms, provided that when R1 is an alkyl group having a C7 backbone, the branching does not consist only of a hexyl group at the a carbon of R1, or only of a methyl group at the γ carbon of R1, or of only single methyl groups at both the β and ω-1 carbons of R1, and provided that when R1 is an alkyl group having a C8 or C11 backbone, the branching does not consist only of a propyl group at the a carbon of R1.
-
公开(公告)号:US20220095927A1
公开(公告)日:2022-03-31
申请号:US17426469
申请日:2020-01-30
Applicant: UCL Business Ltd
Inventor: Edward Zhang , Paul Beard , Rehman Ansari , Nam Trung Hunynh
Abstract: A photoacoustic probe head (200a, 200b) is disclosed. The probe head (200a, 200b) comprises: a Fabry Perot acoustic sensor (202), an interrogation interface (A), an excitation input (B) and a two-axis mirror (204). The Fabry Perot acoustic sensor (200a, 200b) is operable to reflect an optical interrogation beam to create a reflected interrogation beam and to modulate the reflected interrogation beam in response to an acoustic signal at the acoustic sensor (202). The interrogation interface (A) is configured to receive an interrogation beam, and to receive the reflected interrogation beam from the acoustic sensor (202). The excitation input (B) is configured to receive an excitation beam for generating an acoustic field in a sample adjacent to the acoustic sensor (202). The two axis mirror (240) is configured to scan the interrogation beam between different locations of the acoustic sensor (202).
-
-
-
-
-
-
-
-
-